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Ferric Iron Nanoparticle Formation Mediated By 
Negatively Charged Polypeptides 
 
Vamsi Krishna Aluru 
 
The creation of magnetite particles by magnetotactic bacteria has been of great interest for a 
number of years. Previous studies have shown that magnetite nanocrystals have been synthesized 
in the presence of recombinant Mms6 protein. Mms6 plays a vital role in the biomineralization 
of bacterial magnetite nanocrystals. The objective of this research is to determine the effect of 
functional group type on size and shape of magnetic nanoparticles formed by biomineralization. 
Control over the size of nanoparticles is paramount. Use of nanoparticles as contrast agents in 
MRI is advantageous, as they are small enough to be localized in desired region by applying 
local magnetic fields. Sequences VA-Mms6, VA1, VA2, and VA3 were designed with 
modifications in the functional groups Mms6 sequence. Solutions of peptide were mixed with 
ferric and ferro salts and allowed to interact under inert atmosphere. The nanoparticles formed 
are examined under SEM and TEM and compared for differences. The SEM and TEM images of 
nanoparticles produced with the aid of the above peptides had similarity to those produced in the 
magnetotactic bacteria. However, discrete particles with a narrower size range were produced 
using the peptide VA2. XPS, AFM, DLS and MFM were also done on the synthesized 
nanoparticles. The results were in good agreement when compared to those with a standard 
control sample of magnetite nanoparticles. Use of peptides with different functional groups may 
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A biopolymer is formed via a biological route using sugars, amino acids or nucleotides as the 
building blocks. A few examples of biopolymers are cellulose, proteins and DNA. Genetically 
directed biosynthetic routes for producing protein-based polymers allow controlled spatial 
arrangement of macromolecules. Secondary structures and charges on the macromolecules can 
be controlled precisely through biosynthetic routes.  
 
Protein folding, which plays a vital role in the functioning of proteins, can be controlled by 
monitoring amino acid sequence. Materials that have similar properties can be produced by 
mimicking naturally produced protein fibers such as silk, elastin and collagen. A specified 
polymer sequence is produced with high dependability when a gene encoding a target protein is 
translated into the protein sequence at the ribosome.1 Production of a polymer sequence is a two 
step process as shown in Figure 1. First, a particular DNA sequence is converted into a 
corresponding messenger RNA (mRNA) sequence. This step is known as transcription. The 
mRNA sequence serves as a template for protein synthesis. Decoding of mRNA is known as 
translation. Transfer RNA (tRNA) molecules play a central role in translation step. tRNA serves 
as a physical link between the mRNA and the growing polypeptide, and an informational link, 







Figure 1: Schematic diagram of protein synthesis 
 
1.2 Examples of Biopolymers 
 
Silk is obtained from either silkworms or spiders and is one of the strongest natural protein fibers 
available. Because of the good mechanical and functional properties, silk is useful for biomedical 
applications. Silk fibroin from domestic silkworm Bombyx mori (B.mori) is used in medicine as 
sutures and artificial ligaments.2 For centuries, silk fibers have been used as sutures for wounds 
owing to their biocompatibility, low immunogenicity and high strength. Silk fibroins extracted 
from B.mori are spun from aqueous solution and have been used as a scaffold for human aortic 
endothelial cells and human coronary artery smooth muscle cells. In both cases, vascular tissues 
were formed in one week.3 Though silk is used extensively in many biomedical applications, the 
biggest obstacle is the production of silk in large quantities because of the dependence on spiders 
and silkworms to produce the material. Thus, a biomimetic approach has been used in which 
amino acid sequences from silk are used to produce silk-mimetic artificial proteins using genetic 
methods.2 Many attempts to design polymers similar to those of naturally occurring silks have 
been focused on silk protein sequences from B.mori silkworm and samia Cynthia ricini 





silkworms are thought to play a vital role in the mechanical properties of silks.2 These silk 
proteins are mimicked and expressed in host cells like yeast to yield silk like materials. 
 
Elastin is a protein that allows many tissues in body to return to their original shape after 
expansion. The main component of elastin is hydrophobic domain which contains  valine and 
glycine in large quantity.2 The repeated sequence VPGVG mediates the mechanical properties of 
the protein and variations in this sequence have been used to produce elastin-like protein 
polymers.2 Elastin-like polypeptides (ELPs) exhibit an inverse temperature phase transition. 
Below their transition temperature ELPs are soluble in aqueous solutions; however, the proteins 
collapse through hydrophobic interactions at temperatures greater than the transition 
temperature. Elastin-like polypeptides (ELPs) are used in drug delivery systems. Elastin-like 
polypeptides (ELPs) coupled to drugs ,which exhibit a transition temperature between body 
temperature and the temperature in a locally heated region, can effectively be used in treatment 
of solid tumours.4  
 
The above example shows the use of genetically directed techniques to produce protein-based 
materials. Similarly, these techniques can be extended further to produce molecules that mimic 
proteins involved in the formation of nanoparticles in magnetotactic bacteria. To understand the 
mechanism of magnetite formation in bacteria, several proteins tightly bound to bacterial 
magnetite proteins in M. magneticum AMB-1 were isolated by Arakaki and co.5  They used these 
proteins to nucleate the formation of magnetite extracellularly. 
 
1.3 Synthesis of Iron Nanoparticles via chemical routes 
 
Iron particles can be synthesized using chemical and biological routes. The following are a few 
examples of chemical routes to synthesize iron nanoparticles. 
 
1.3.1 Co-precipitation  
 
Crystalline iron particles can be synthesized from aqueous Fe2+/Fe3+ salt solutions by the 




the pH and ionic strength of the precipitation medium. As the pH and ionic strength of medium 
increases, size of the particles decreases.7 The chemical composition of the surface and the 
electrostatic surface charge of the particles are influenced by pH and ionic strength of medium. 
In this method, it is possible to control the mean size of particles between 2nm to 15nm. Owing 
to the huge surface-area to volume ratio, nanoparticles produced by co-precipitation tend to 
aggregate in solution in order to reduce their surface energy.8  
 
1.3.2 Thermal Decomposition 
 
Thermal decomposition of organometallic compounds (metal acetylacetonate, where the metals 
can be Fe, Mn ,Co, Ni or Cr), in the presence of surfactants results in formation of magnetic 
nanocrystals.9 The control over the size and morphology of the particles depends upon the initial 
ratio between organometallic compounds, surfactants and solvent. Based on the pyrolysis of 
metal fatty acids (decanoic acid, lauric acid, myristic acid, palmic acid, oleic acid, stearic acid) in 
non-aqueous solutions, a decomposition method was followed by Peng and co-workers to 
synthesize magnetic oxide nanocrystals.10  Fe3O4 nanocrystals over a size range of 3-50 nm were 
synthesized. Variation in the reactivity and concentration of the precursors can be used to control 
the size and morphology of nanocrystals. The reactivity was adjusted by changing the chain 
length and concentration of fatty acids; the shorter the chain length, the faster is the reaction rate.  
Hyeon and co-workers used nontoxic iron (III) chloride and sodium oleate to prepare 
monodisperse iron oxide nanoparticles.11 Depending on the decomposition temperature, particle 
sizes over a range of 5nm-22nm were formed. The nanoparticles formed by this method were 
dispersible in organic solvents, but in most biomedical applications water dispersible magnetic 
particles are desirable.9 One of the disadvantages to thermal decomposition is the time 
consuming and complicated process. 
 
1.3.3 Two phase method (Microemulsion) 
 
In order to obtain metal oxide nanoparticles, microemulsions such as water in oil are being 
investigated. A microemulsion is a thermodynamically stable isotropic dispersion of two 




These microemulsions coupled with surfactants offers a distinct environment for the growth of 
nanoparticles.9 Carpenter et al. prepared metallic iron particles coated by a thin layer of gold.13 
Coating protects the iron core from oxidation, making them applicable in biomedicine. The 
nanoparticles formed via microemulsion methods are difficult to scale-up and the properties of 
the particles are adversely affected by the residual surfactants. Nanoparticles synthesized by this 
method have particle sizes which vary over a wide range; moreover the yield of nanoparticles is 
very low when compared to thermal decomposition and co-precipitation. Synthesis of 
nanoparticles at industrial level requires high temperatures, pH, and pressures and results in 
formation of toxic byproducts. Table 1 gives an overall comparison of the synthetic methods 
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1.4 Biomineralization 
 
Because of the high temperature and time often required to make nanoparticles, 
biomineralization is a new technique being investigated. Biomineralization refers to processes by 
which organisms make minerals. Until the early 1980s biomineralization was known as 
“calcification” due to the predominance of biologically formed calcium-containing minerals. 
Over a period of time, many more biogenic minerals were discovered and a more specific term 
“biomineralization”, was given. A high degree of control is exerted by organisms over mineral 
formation in biomineralization. A few examples of biominerals are carbonates, phosphates, 




their degree of biological control. In the 1980‟s Lowenstam introduced these processes as 
“biologically induced mineralization” (BIM) and “biologically controlled mineralization” 
(BCM). There is a marked difference between the two processes in terms of the functionality of 
the biomineralized particles. Particles that are produced by BIM have no function except that 
they might act as a form of protection from different environments, whereas particles produced 
by BCM have high degree of crystallinity. Particles formed by BCM have definite shape and size 
which makes them useful in many biomedical applications. One of the best examples of BCM is 
the formation of magnetic nanoparticles in magnetosomes within the magnetotactic bacteria. 
Biomineralization of magnetite has also been found in algae,16 insects,17 birds and even 
humans.18 
 
1.5 Magnetotactic Bacteria 
 
Magnetotactic bacteria are aquatic prokaryotes that can move under the direction of a local 
geomagnetic field. The term magnetotactic bacteria, was first cited in a publication in 1963 
written by Salvatore Bellini. R.P. Blakemore observed that under the influence of a magnetic 
field, bacteria migrated from south to north, giving rise to the term magnetotactic.19 This 
behavior is attributed to the existence of cytoplasmic membrane vesicles termed „magnetosomes‟ 
which enclosed magnetite particles of uniform morphology.19 Different strains of magnetic 
bacteria show different migration patterns under local geomagnetic fields. Magnetic bacteria 
discovered in Northern Hemisphere migrate parallel to the magnetic field, show a northward 
migration under the influence of geomagnetic field , and are termed north-seeking (NS) 
magnetotactic bacteria.19 Magnetotactic bacteria discovered in southern hemisphere migrate anti-
parallel to the local geomagnetic fields, show a southward migration in the geomagnetic field , 
and are termed south-seeking  magnetotactic bacteria.20 The magnetotactic bacteria discovered 
near equator were equally distributed south-seeking and north-seeking bacteria.21 
 
After the discovery of the first magnetotactic bacterial strain, there were reports of magnetotactic 
bacterial strains from marine and fresh water.22,23,24 Magnetotactic bacteria have different cellular 
morphologies; they can be cocoid, rod-shaped, helical or multicellular”.22,25 Despite their 




bacteria possess magnetosomes and are motile. Magnetotactic bacteria are very sensitive to 
environmental oxygen concentration and most of them can only synthesize magnetosomes in 
very low oxygen concentrations.26 All magnetotactic bacteria reported to date are gram-negative 
bacteria. Gram-negative bacteria are those which do not retain the crystal violent dye in gram in 
the gram staining protocol. 
 
Magnetotactic bacteria discovered to this point fall into one of the following categories: 
microaerophiles, anaerobic or both.25 In aqueous environments magnetotactic bacteria are found 
in great numbers in an oxic-anoxic transition zone (OATZ). Magnetotactic bacteria can 
synthesize magnetosomes only if low oxygen concentrations are present. In general, if the initial 
oxygen concentration in the atmosphere of cultures is higher than 6%, these bacteria cannot 
synthesize magnetite.23  
 
1.5.1 Bacterial Magnetite Particles 
 
Magnetotactic bacteria produce two types of minerals; iron oxides and iron sulfides. The type of 
mineral biomineralized is dependent on the external environment in which bacteria survive. The 
magnetotactic bacteria that produce iron oxides biomineralize magnetite (Fe3O4) and those that 
produce iron sulfides biomineralize greigite (Fe2+Fe3+2S4) and sometimes pyrites (FeS2).27 
Magnetite is found in bacteria from microaerobic fresh water and marine environments, whereas 
greigite is found in bacteria from marine environments only. First direct evidence of magnetite 
was found in 1979 by R.P.Blakemore when he isolated the first pure culture of magnetotactic 
bacteria, Magnetotactic Spirillium strain MS-1.23 With the help of Mossbauer spectroscopy, 
Frankel et al. concluded that the iron containing mineral present was Fe3O4 .Magnetite particles 
so synthesized had high chemical purity and had an average size of 50nm.24 Some magnetotactic 
bacteria synthesize both magnetite and greigite.25 
 
All magnetosomes are of size 35-120nm regardless of their composition. The morphologies of 
the crystals reported to date fall into three categories; cuboidal, elongated prismatic and tooth-, 
bullet-or arrowhead-shaped.25 Particles of size range 35-120nm formed stable single magnetic 




in the chain. Magnetite particles within SMD range are permanently magnetic and their magnetic 
moment remains stable under ambient conditions.28 Particles whose size is less than 35 nm tend 
to be super paramagnetic and their net moment approaches zero. Particles with size greater than 
120 nm are non-uniformly magnetized as multiple magnetic domains are formed. The 
magnetostatic interactions between particles results in the formation of a permanent magnetic 
dipole. A cell requires twenty 50nm magnetosomes to have sufficient magnetic dipole moment 
for orientation along geomagnetic field.26 The magnetite particles which are synthesized are 
aligned in chains ,and these chains act as compass needles and help in migration of 
magnetotactic bacteria.25 
 
Synthesis of bacterial magnetosomes is a multistep process and involves - 1) magnetosome 
vesicle formation 2) iron uptake into the cell and then into the magnetosome vesicle and 3) 
magnetite or greigite biomineralization.5 Synthesis of magnetite particles involves three stages: 
First, ferric ions are taken up by the cell through a specific iron transport and then reduced to 
ferrous ions and transported into magnetosome vesicles. Second, ferrous ions are reoxidized to 
ferric ions and form hydrous ferric oxides. Third, one-third of ferric ions in ferric oxides are 
reduced into ferrous ions forming magnetite particles with defined morphology. 29,25 Different 
strains adopt different routes to transport iron into vesicles. In the Magnetospirillum Magneticum 
strain AMB-1, iron is transported in the form of Fe (II).30 Figure 2 shows the schematic 
mechanism of iron uptake in Magnetospirillum Magneticum strain AMB-1. 
 
 
Figure 2: Schematic diagram of iron uptake mechanism in Magnetospirillum Magneticum strain AMB-1 
(FRAMES 1-4) 
First iron is reduced from ferric to ferrous at cell wall. Next, Fe+2 is transported to cytoplasm 














(Frame 4). In Magnetospirillum Magneticum strain MS-1 Fe (II) is transported with the aid of 
siderophores.31 In the Magnetospirillum gryphiswaldense strain, MSR-1, iron is taken in the 




Magnetosomes are cell organelles with the magnetite crystal inside and an outer cover of a lipid 
bilayer membrane. The membrane is made up of phospholipids and has a similar composition as 
the cytoplasmic membrane.28,25, 33 The term „magnetosome‟ was first used by Balkwill et al. to 
describe “the electron-dense particles and their associated bounding layers in magnetotactic 
bacteria”.33 Individual magnetosomes are linked to form chains, and they are attached to inner 
cytoplasmic membrane of the cell. 
 
In 1988, Gorby et al. characterized the magnetosome membrane for the first time.34 The 
components of magnetosome membrane are mainly phospholipids, fatty acids and some proteins 
that were similar to those observed in cytoplasmic membrane. Although the composition of a 
magnetosome membrane is similar to cytoplasmic membrane, there was no clear evidence of the 
formation of magnetosome until 2006.35  In 2004, Komeili et al. showed the existence of 
magnetosome vesicles prior to magnetite formation in Magnetospirillum magneticum strain 
AMB-1, and protein MamA was required for their activation.36 Deletion of the mama gene, a 
gene encoding MamA, resulted in shorter magnetosome chains being synthesized inside the 
cells. Komeili proposed two possible functions of the protein MamA in magnetosome formation: 
1) it may be involved in magnetosome assembly, 2) it may be used by magnetotactic bacteria to 
control the number of magnetosome vesicles they synthesize. In 2007, Komeili et al. studied the 
molecular mechanism of magnetosome formation in Magnetospirillum magneticum strain AMB-
1.28 Magnetosome formation involves three steps: invagination of cytoplasmic membrane to 
form magnetosomes, assembly into a chain templated by proteins Mamk and MamJ, and 
transport of iron into vesicles and synthesis of magnetite crystals with definite shape and size, 





1.5.3 Bacterial Biomineralization Protein-Mms6 
 
There are some proteins that are specific to the membrane and are responsible for magnetite 
crystal growth. One such protein Mms6 was first reported by Arakaki et al who characterized a 
number of proteins in Magnetospirillum magneticum strain AMB-1. Mms5, Mms7, Mms13 were 
few other proteins that were isolated and characterized.5 All these proteins have a hydrophobic 
N-terminal region and a hydrophilic C-terminal region. The most interesting conclusion from 
this report is that magnetite nanoparticles with similar morphology to bacterial magnetite 
particles can be synthesized in vitro in the presence of purified recombinant Mms6 expressed in 
E.coli. Figure 3 shows the electron micrographs of magnetic particles synthesized in presence 
and absence of Mms6.5 
 
 
   Figure 35 : A) iron crystals in presence of Mms6   B) iron crystals in absence of Mms6 
 
Iron produced in the presence of Mms6 showed cuboidal morphology, with size ranging from 20 
to 30 nm (Figure 3A), whereas the magnetic particles produced in absence of Mms6 were non-
homogeneous in size (1-100nm) (Figure 3B). In 2007, Prozorov et al. reported magnetization 
measurements and structural characterization of magnetite nanoparticles synthesized in presence 
of recombinant Mms6.37 BSA, ferritin and Lcn2 were used as controls to compare magnetite 
particles synthesized in presence of proteins with different iron binding properties. These reports 
showed that magnetite particles with uniform morphology can only be synthesized in presence of 
recombinant Mms6.37 
 
Prozorov et al. reported the synthesis of cobalt ferrite nanocrystals in the presence of Histidine-




polymers to act as a template for synthesizing cobalt ferrite nanocrystals. Alternatively cobalt 
ferrite nanocrystals were synthesized by attaching C-terminus of Mms6 to self-assembling 
polymers.  Complex magnetic crystalline nanomaterials of particle size 40-100nm were produced 
, and these sizes with high degree of crystanility are difficult to produce using conventional 
techniques. The hydrophilic C-terminal region of Mms6 contains amino acid residues with either 





    
Figure 4:  Amino acid sequence of Mms6 deduced from the DNA sequence. 
     
Arakaki et al. proposed that Mms6 may act as a template for magnetic nanoparticles synthesis 
and control the morphology of magnetite particles formed.5 The exact role of Mms6 in magnetite 
crystal formation remains still unclear. 
 
1.6 Applications of Magnetic Nanoparticles 
 
No matter the method of synthesis, the magnetic nanoparticle has a number of potential 
applications. Magnetic nanoparticles are widely being used for cell separation,39 automated DNA 
extraction,40 drug delivery and targeting41 and magnetic resonance imaging.8 Nontoxicity, 
biocompatibility and injectability are the important properties of magnetic particles which make 
them potential candidates for application in medicine. Magnetic cell separation has been carried 
out using antibodies that bind to proteins. DNA extraction is an important technique for DNA 
sequencing, and an automated DNA extraction process is useful in clinical fields. DNA can be 
separated from cell contaminants and debris by using magnetic particles. Use of magnetic 
particles over conventional separation methods reduces use of chemicals and increases the ease 
of separation of DNA.40 
 
Chemotherapeutic drugs are non-specific and this nature makes them disadvantageous for 




cells. Use of magnetic nanoparticles as carriers for cytotoxic drugs increases the uptake of drug 
at the target site. Therapeutic compounds are attached to biocompatible magnetic nanoparticles 
and high magnetic fields are used to guide the drug to tumor locations.41 Magnetic particles are 
attracted to higher magnetic flux density and this feature is used in drug targeting. Currently, 
magnetic nanoparticles are being used as contrast agents for magnetic resonance imaging. Figure 
5 is a schematic illustration of the therapeutic strategy using magnetic nanoparticles. Magnetic 
particles can be used for diagnosis as well as cancer therapy simultaneously. Use of magnetic 




: Functionalized magnetic nanoparticles accumulate in the tumor tissues via the drug delivery 
system (DDS). Magnetic nanoparticles can be used as a tool for cancer diagnosis by magnetic resonance 
imaging (MRI). Hyperthermia can be induced using alternating magnetic fields. 
 
With these applications, synthesizing particles of specific size and shape by methods conducive 

















1.7 Purpose of Study 
 
It is clear that protein mediated synthesis of magnetic nanocrystals is a potential route for 
synthesis of well defined nanoparticles. Nanoparticles can be produced extracellularly, by 
making use of bacterial mineralization proteins against conventional chemical routes which often 
involve high temperatures and pressures. One such protein, Mms 6, isolated from the strain 
Magnetospirillum magneticum strain AMB-1 showed the ability to bind iron to produce 
homogeneous magnetic nanoparticles. Binding of iron was attributed to the presence of hydroxyl 
and carboxyl groups present in the C-terminal hydrophilic region. The amino acid residues that 
possibly bind iron in Mms 6 sequence are bolded. 
 
 
Serine(S), aspartic acid (D), glutamic acid (E) and tyrosine (Y) are the amino acid groups with 
functional groups hydroxyl and carboxyl, their structures are given in Table 2.  
 
Table 2: Amino acids and their Structure 
 
Amino Acid Structure 
   Serine (C3H7NO3) 
 
  Aspartic Acid 
(C4H7NO4)  
  Glutamic Acid 
(C5H9NO4) 
 
  Tyrosine (C9H11NO3) 
 
  
The following sets of sequences were designed as variations in amino acids in Mms 6. VA1 has 
only hydroxyl groups(S, Y), VA2 has only carboxyl groups (D, E), and VA3 has combination of 
both hydroxyl and carboxyl.  





The above sequences are designed in order to compare with the sequence that is available from 
literature. Table 3 shows the newly designed peptides. 
 
Table 3: Designed Peptides 
 
VA1 GAVYAYGKSRSIYSAQSYSSVSLRY 
VA2  GAVDADGKERDIDEAQEDEEVDLRD 
VA3  GSEDAYGSYDESYDEQSEDYESYYS 
  
The project addressed in this proposal involves inspecting the relative ability of functional 
peptides to bind iron by changing the amino acid sequence and most importantly to see whether 
there is a change in the shape of crystals formed with different peptide functionality.39 The three 
sequences were designed to test to what extent carboxyl and hydroxyl functional groups play a 






Materials and Methods 
 
Production of protein polymers via biologically directed methods helps to create molecules with 
well defined sequences and functionality. These properties cannot be controlled in chemically 
synthesized molecules. A cloning strategy (Figure 6) for production of protein polymers is 
employed. Figure 6 shows how an insert is cloned and expressed in DNA plasmids to produce 
amino acid polymers.  
 
 




E.coli plasmids pUC19, pET19b and pET24a were purchased from Invitrogen (Carlsbad, CA). 




England Biolabs (Beverly, MA). Oligonucleotide and plasmid purification kits and nickel-
cheleated sepharose resin were obtained from Qiagen (Valencia, CA). General reagents for 
protein expression and purification were purchased from Sigma (St. Louis, MO) and Fisher 
Scientific (Fairlawn, NJ). All inserts in initial phase of research were obtained from Invitrogen, 
while altered pJ414express, pJ201, and pJ241 were obtained from DNA 2.0 (Menlo Park, CA). 
 
2.2 Design of New Plasmids and Ongoing Research Work 
 
The oligonucleotide sequence of Mms612 described by Atsushi Arakaki et al. was modified as 
VAMms6. Other sequences were designed by replacing amino acids in Mms6 with hydroxyl and 
carboxyl amino acids to test how functionality differences affect binding of iron and nucleation 
of magnetic nanoparticles. These three sequences, VA1, VA2, and VA3 were designed for 
comparison with the control VAMms6. Figure 7 shows the sequences. Change in the sequences 
may alter the binding of iron to the peptides formed. VA1 contains functionality of hydroxyl 
groups from the side chains of serine (S) and tyrosine(Y). VA2 contains only carboxyl functional 
groups i.e. aspartic acid (D) and glutamic acid (E). VA3 contains both hydroxyl and carboxyl 
functional groups. These designed sequences were ordered in the cloning plasmids pJ201 or 
pJ241 from DNA 2.0. The inserts were designed with BamH1 and HindIII ends to ensure a 
proper ligation of the inserts into the expression plasmid pET24a. The DNA was received as 2µg 
of dry DNA and a stab culture in NEB-10 Beta cells. Cell stocks were made from the stab culture 
by streaking on plates with solid media containing kanamycin, matching the antibiotic resistance 









Figure 7: DNA sequence of new designed inserts with BamH1 and HindIII ends (* denotes stop codon) 
 
2.3 New Expression Construction 
 
The cloning plasmids were digested with enzymes BamH1 and HindIII for 30 min at 37°C in an 
incubator. The inserts were purified via 1% agarose gel electrophoresis. The expression vector 
pET24a was also digested with enzymes BamH1 and HindIII for 30 min at 37°C in an incubator. 
pET24a was dephosphorylated via treatment with CIP and purified using nucleotide removal kit. 
The inserts VAMms6, VA1, VA2 and VA3 were then ligated into pET24a. The ligated mixture 
was then transformed into chemically competent BL21 cells and 50µl of culture was spread on 
plates with solid media containing ampicillin and chloramphenicol antibiotics. These plates were 
incubated overnight at 37°C in an incubator. 
 
The peptide sequences of VAMms6, VA1 and VA2 were ordered in expression vector pJ414. 
These sequences were ordered to eliminate the steps of ligation of insert into the expression 




stocks of VAMms6, VA1, and VA2 were made from the stab culture by streaking on plates with 
solid media containing ampicillin. Dry DNA was suspended in 20µl of sterile water. DNA was 
transformed into chemically competent BL21 cells. The cells were spread onto petri dishes with 
solid media containing ampicillin and chloramphenicol antibiotics. These plates were incubated 
overnight at 37°C in an incubator. Single colonies were obtained from the petri dishes and put 
into 5ml cultures of liquid media. Culture tubes were shaken and placed in an incubator 
overnight at 37°C.  Cell stocks of VAMms6, VA1, and VA2 in BL21 cells were made for future 
use in peptide expression. 50 mg of peptide VA3 was ordered from (Genscript, NJ). VA3 was 
ordered to carry out co-precipitation reaction with iron solution and analyze the particles formed 
under a Transmission electron microscopy (TEM). 
 
2.4 Protein Expression  
 
Cells from the cell stock of VAMms6, VA1 and VA2 in BL21 cells were used to inoculate a 50 
ml starter culture in 2xTY media containing ampicillin (200µg/ml) and chloramphenicol 
(35µg/ml). Starter culture was shaken in an incubator overnight at 37°C. 500ml of 2xTY media 
was inoculated with 10 ml of the starter culture and 500 µl of each antibiotic ampicillin and 
chloramphenicol. This culture was shaken in an incubator at 37°C until the optical density 
measured at 600nm (OD600) reached a value of to 0.8±0.1. At that point, protein expression was 
induced by the addition of 500 µl (0.41M) of isopropyl-β-D-thiogalactopyranoside (IPTG) and 
the cultures were grown for 4 more hours. After addition of IPTG, OD of samples was taken 
every one hour. At the end of 4 hours, cells were harvested by centrifugation (7000rpm, 15min), 
the supernatant was discarded, and the cell pellets were resuspended in 8M Urea Buffer at pH 8 
(1g cell/5 ml of buffer) and stored in -20°C freezer. The samples that were collected during 
protein expression were also centrifuged and the cell pellets were resuspended in TE Buffer. 
 
2.5 Protein Purification 
 
The suspended cell pellets in 8M urea buffer were thawed before sonication. Sonication was 
performed for 50 seconds with 2 seconds pulse on and 10 seconds pulse off. The cells were then 




the supernatant was saved and the cell debris that precipitated at the bottom was discarded. The 
reserved supernatant was then incubated with Nickel-NTA resin for an hour at room temperature, 
shaking the beads continuously. The unbound proteins were separated from the nickel resin using 
a gravity-flow column. The flow-through of unbound molecules was saved for SDS-PAGE 
analysis. The nickel resin was washed with different pH buffers of 8M urea. First, a urea buffer 
of pH 6.3 was used to wash the column. Then, the target proteins were eluted with urea buffers 
of pH 5.9 and pH 4.5. Optical density measurements were taken at 280 nm wavelength. All the 
flows through fractions from the wash steps were saved for future analysis by sodium dodecyl 




Induction profiles were observed for all the peptides by running SDS-PAGE of samples that 
were collected during protein expression, before and after induction. Similarly protein 
purification profiles were also obtained via SDS-PAGE. The separating gels were made at 15% 
polyacrylamide concentration while the stacking gels were made at 6% polyacrylamide 
concentration. All the wash fractions from protein purification were loaded and the gel was run 
at 100V for 90 min. The gels were visualized using Coomassie blue stain. The gels were stained 
for 30 min and then destained overnight at room temperature. 
 
2.7 Amino Acid Analysis 
 
After purification of the peptides, the peptides were dialyzed and stored at -80°C. They were 
freeze dried, and the lyophilized material was sent out for amino acid analysis to confirm the 
presence of the desired peptides.  All peptide samples were sent to the UC Davis Proteomics 




2.8 Western Blots 
 
Western Blots were used to confirm the presence of the desired peptide with a His-tag.                    
SDS-PAGE was run to separate the proteins by the length of the polypeptides. The proteins were 
transferred onto a PVDF membrane by electrophoresis for 1h 15min at 45v. The membrane was 
washed in Tris-buffered saline (TBS) for 5 minutes and blocked using a blocking buffer 
purchased from Qiagen. The membrane was washed three times with TBS with Tween-20 (TBS-
T) for 5 minutes a wash. The membrane was incubated with anti-His antibody at a dilution of 
1:2000 in blocking buffer overnight. The membrane was washed three times with TBS-T. The 
first wash was for 5 minutes, the second and third was for 10 minutes and 15 minutes 
respectively. A chemiluminescent technique was used to detect the florescence. 
Chemiluminescent is a technique that involves incubation of the western blot with a substrate 
and in the process light is emitted due to a chemical reaction. The membrane was developed in 
1ml of lumiglo for one minute. The florescence of the antibodies was detected by placing the 
membrane on a plastic film and exposing the film for two minutes. 
 
2.9 Synthesis of Magnetite nanoparticles using recombinant proteins 
 
Magnetite nanoparticles were synthesized via co-precipitation of FeCl2 and FeCl3 aqueous 
solutions in the presence of one of the recombinant proteins, VA-Mms6, VA1, VA2, or VA3. 
The following stoichiometric reaction is a balanced equation of magnetite formation. 
 
Equation 1: Stoichiometric equation of magnetite formation 









The undesired reaction takes place if the reactants are exposed to atmosphere. The synthesis of 
magnetite nanoparticles was carried out in a glove box in order to provide the reaction media an 
inert nitrogen atmosphere. 100µl of 0.6M FeCl3 and O.3M FeCl2 were added to 10µl of peptide 
solution (5mg/ml) in a 10ml round bottomed flask. All the solutions were degassed with argon 
for 3 minutes prior to their use. The reaction mixture was titrated slowly with 0.1N NaOH 




slowly changed to brownish-yellow and finally to black. The formed iron particles were left to 
grow in sealed flasks for 7 days. At the end of 7 days, particles settled to the bottom of the flask 
and were further concentrated at the bottom using boron-neodymium magnet. The precipitate 
was then washed with degassed water and vacuum dried overnight at room temperature. 
Synthesis of magnetite was also carried out using polyethylene glycol (PEG) attached to the 
peptides VA2 and VA3. PEG was dissolved in 1ml of DMSO. To this VA2 or VA3 (1mg/ml), 
HBTU solution (a peptide coupling reagent) and N, N-Diisopropylethylamine (DIEA) were 
added. Definite volumes of HBTU and DIEA were added every 3 hours and the whole reaction 
mixture was stirred at room temperature overnight. The reaction mixture was dialyzed and stored 
in -80 °C freezer. The coupled peptides (PEG-VA2 or PEG-VA3) were used to synthesize iron 
particles similar to the methods used with VAMms6, VA2 and VA3 to synthesize iron particles.  
 
2.10 Characterization of Magnetite Nanoparticles 
 
2.10.1 Scanning Electron Microscopy  
 
Energy dispersive X-ray spectroscopy (EDS or EDX) is an analytical technique used for the 
elemental analysis or chemical characterization of a sample. The samples were imaged by 
scanning electron microscope and analyzed by EDS. The precipitate was dried on a copper tape 
stuck to an aluminum stub. The copper tape was used to increase conductivity and smoothness of 
surface. EDS was performed by Adrienne MacLeod McGraw. (WVU) 
 
2.10.2 Transmission Electron Microscopy (TEM)   
 
For TEM specimen preparation, the sample was first diluted with ethanol. After the solution was 
sonicated for about 10 minutes, a drop of the solution was transferred to a 200 mesh copper grid 
with carbon support and was then left to dry in ambient condition. TEM characterization was 
performed using a JEM-2000FX operating at 200kV. Selected area electron diffraction (SAED) 






2.10.3 X-ray Photoelectron Spectroscopy (XPS) 
 
XPS is a quantitative technique used to measure elemental composition, chemical state and 
electronic state that exists in a material. The XPS system used in these studies was a Physical 
Electronics 5700 ESCA system, equipped with both a standard Al/Mg x-ray source (energies of 
1456/1253 eV respectively) and a monochromatic Al source. The system was calibrated to the 
Au 4f7/2 peak to ensure linearity in the (binding) energy scale. The dried precipitate was placed 
on a silicon wafer and XPS was performed by Srikanth Raghavan. (WVU) 
2.10.4 Dynamic Light Scattering 
The size of particles synthesized were determined by dynamic light scattering (DLS; DLS-7000, 
Otsuka Electronics) for a sample dispersed in aqueous suspension after vortexing. The median 
diameter (number basis) was determined from the obtained size distribution. Dynamic light 
scattering was done with the help of Aaron Kessman. 
 
2.10.5 Atomic Force Microscopy (AFM) 
 
All atomic force microscopes have the same basic components: laser, cantilever, photodiode, 
controller, scanner, and computer. In AFM, the force transducer is a deflecting cantilever on 
which a sharp tip is mounted. The cantilever and tip assembly is scanned with respect to the 
surface to get the morphology of the surface. Using the laser light reflected from the cantilever 
back, a photodiode collects data on the deflection of the cantilever. 
 
The system used for our measurements was calibrated using standards produced by Mikro-Mash. 
The standards used for this step were 20 nm ±1 in height. The AFM was mounted on a Minus K 
vibration isolation table inside of a Herzan acoustic isolation hood. The precipitate was vacuum 
dried on silicon carbide wafers and AFM was performed. AFM was performed with the aid of 
Srikanth Raghavan (WVU). 






2.10.6 Magnetic Force Microscopy (MFM) 
 
Magnetic force microscopy was performed on the samples. For the MFM, the tips have to be 
magnetic in nature. Magnetic nature enables the tip to detect any magnetic force from the sample 
onto the tip. All tips vibrate at a natural frequency called the resonance frequency. The thickness, 
length and width were typically 3μm, 225 μm and 28 μm respectively. The natural frequency or 
the resonance frequency of the tips was around 75 kHz. MFM instrument which was used for the 
purpose of this research is (manufactured by Agilent Technologies formerly Molecular Imaging, 
product name: 5500 SPM).  
 
The height at which the tip is placed is called the “Interleave Height” or simply “Lift Height”.  
Net magnetic force depends heavily on the tip-sample separation or the „interleave height‟. The 
interleave height used for this research was 100 nm. It is important that the interleave height be 
greater than the highest features of the surface topography, if not the probe could actually crash 
into the sample surface. In order to maintain a constant interleave height throughout the 
experiment, the tip is usually pulled away from the sample by a value well above the interleave 
height and then brought back to the level of interleave. This particular value of pulling away 
from the sample is called as “Pullaway Height”. The pullaway value used for this research was 











Results and Discussions 
 
VAMms6 was ordered in expression vector pJexpress414, whereas VA1, VA2 and VA3 were 
ordered in cloning vector pJ201. The oligonucleotides VA1, VA2, and VA3 which are 170bp 
long, were digested from cloning vector pJ201 using the enzymes BamH1 and HindIII. Figure 8 





 Figure 8: Lane 1) 100bp Ladder, Lane 2) VA1, Lane 3) VA2, Lane 4) VA3, 1.5% gel, 40 min @ 100V, stained 
with SYBR gold 
 
Two bands were observed in each lane numbered from 2 to 4 in Figure 8. One band was seen 
above 1500 base pair and other band was seen approximately at 200 base pairs as seen in 
comparison to the molecular weight ladder in lane 1. These bands are at the expected molecular 
weight of the insert (170bp) and the remainder of the plasmid after digestion. The observed 
bands of inserts were cut from the agarose gel and purified using a Qiagen purification kit. In 
order to transfer inserts VA1, VA2 and VA3 into expression plasmid, pET24a was digested with 
BamH1 and HindIII, later purified using nucleotide removal kit. 
 
pJ201 













An agarose gel was run to determine the concentration of the insert and vector for subsequent 
calculations of ligating the inserts into the expression plasmid pET24a. Figures 9(a) and 9(b) are 
the images of concentration gel.    








Figure 9 (a): Lane 1) 1 kb ladder, Lane 2) digested pET24a, (b) Lane 3) 100bp ladder, Lane 4) VA1,          
Lane 6) VA2, Lane 7) VA3, 1.5% gel, 35 min @ 100V, and stained with SYBR gold 
 
 
In comparison to the molecular weight ladders, a band was observed at about 5000bp as seen in 
Figure 9(a) and bands were observed at around 200 base pairs as seen in Figure 9(b). These 
bands were at the expected molecular weight of the digested pET24a (5140 bp) and the inserts 
(170 bp). The concentrations of the DNA segments were determined by comparing the 
fluorescence intensity of the sample DNA with that of the band of comparable size in the 100bp 
DNA ladder, which contains a known concentration of DNA. Similarly, concentration of 
digested expression plasmid pET24a was determined by comparing the fluorescence intensity of 
digested pET24a with the fluorescence intensity of the closest corresponding band in the 1kb 
DNA ladder. The relative intensity of the inserts was taken to be half of the intensity of 200 bp 
marker, indicating a concentration of approximately 12ng/µl. The expression plasmid had the 
pET24a 5kb 
1     2  
Inserts VA1, VA2, VA3 200bp 
100bp 
 




same intensity as that of 5kb marker and therefore is at a concentration of approximately 























                       (2) 
 
where, T is the volume of total ligating solution, Vl is the vector length, Vc is the vector 
concentration, Vv is the vector volume, Il is the insert length, Ic is the insert concentration, Iv is 
the insert volume and Ir is the required insert-to-vector ratio for ligation. 
 
Ratios of 300:1 and 600:1 (insert:vector) were used for ligation of  inserts into vector pET24a. 
The ligated DNA was transformed into BL21 cells but the ligations were unsuccessful as there 
were no colonies on petri dishes. The ligations proved futile and hence to eliminate the ligation 
steps, VA1 and VA2 were ordered in expression plasmids pJexpress 414. 
 
3.1 Protein Expression 
 
Cells from the cell stock of VAMms6, VA1 or VA2 in BL21 were used to inoculate a 50ml 
starter culture in 2xTY media containing ampicillin (200µg/ml) and chloramphenicol (35µg/ml).  
A starter culture was shaken in an incubator overnight at 37°C. Culturing media (500ml) was 
inoculated with 10ml of the starter culture and 500µl of each antibiotic ampicillin and 










Table 4: Optical density values of pJexpress414-VAMms6, pJexpress414-VA1, and pJexpress414-VA2 






at 600nm (BL 21 
cells) 
pJexpress414 
–VA1 (Time in 
hours) 
Optical density 
at 600 nm (BL 
21 cells) 
pJexpress414 –
VA2         (Time 
in hours) 
Optical density 
at 600nm (BL 21 
cells) 
2.5 0.791 2.5 0.769 2.5 0.773 
3.5 1.19 3.5 1.52 3.5 1.55 
4.5 1.30 4.5 1.95 4.5 1.90 
5.5 1.73 5.5 2.05 5.5 2.10 
6.5 1.80 6.5 2.54 6.5 2.25 
*time points after 2.5, samples were diluted to determine the OD value. Values reported are corrected with the 
dilution factor 1/10 
 
The cells that were harvested after expression were purified under denaturing conditions. 
Purification under denaturing conditions involves a series of washes with 8M urea buffer at 
different pH values of 6.3, 5.9 and 4.5. The purified fractions were collected and analyzed on a 
SDS-PAGE gel. The gel was visualized using Coomassie blue staining. Figure 10 shows the 





Figure 10: Protein purification profile of VA-Mms6, VA1 and VA2, 12.5 % separating gel, ran @100V, 
Lane1) Protein ladder, Lane 2) VA-Mms6 Lane 3) VA1 and Lane 4) VA2 
 
Two bands were observed in lane 2, one between 10 kD-15 kD and the other between 20 kD-25 
kD as compared to the molecular weight ladder in lane 1. VA-Mms6 (8.7 kD) is expected to run 
higher due to the presence of highly charged functional groups. A second band seen at around 
Protein             Mol.wt. 
VA-Mms6         8.7 kD 
VA1                  7.8 kD 

















20kD reveals the folding of peptide VA-Mms6. In lane 3 there were no bands. Repeated number 
of purifications did not yield VA1; reason being VA1 was not properly expressed. In case of 
VA2, as seen in lane 4, there was a single band seen at roughly 10 kD. This band is slightly 
higher than expected, owing to the presence of negatively charged carboxyl functional groups in 
VA2. This purification profile showed that VA-Mms6 and VA2 were reproducible whereas, 
VA1 cannot be expressed and hence is not used in further study. 
 
3.2 Amino Acid Analysis 
 
The results from amino acid analysis are shown in Appendix A. After purification and 
lyophilization, samples were sent out for amino acid analysis. The amino acid analysis was 
performed by digesting the peptide with HCl and reducing the peptides to their amino acid 
components. The digested material was analyzed using chromatography.  The result was reported 
in nmol/injection of each amino acid. Based on the amino acids present in the peptides, the 
percent content of each amino acid was compared to the expected percent. It is seen that the 
deviation of the observed results were less than ±2% of the expected value. The observed and 
expected mole percentage of amino acids was in good agreement with the amino acid analysis of 
the peptides VA-Mms6 and VA2, indicating that proteins of interest had been produced.  Amino 
acid analysis was done at UC, Davis CA in Proteomics Core Facility. 
 
3.3 Western Blot 
 
A western blot was run to detect proteins with His-tag. Western blot is an electrophoretic 
technique where the proteins are separated based on their charge and mass. Specific antibodies 
are used to detect the presence of specific proteins. A chemiluminescent detection method was 






Figure 11: Western Blot Stained with anti-His antibody, Lane1) purified His-tagged VA-Mms6; Lane 2) 
purified His-tagged VA1; Lane 3) purified His-tagged VA2 
 
The protein bands that were visible on the SDS-PAGE were also observed on the PVDF 
membrane at the same molecular weight, confirming the presence of proteins. For VA-Mms6 in 
lane 1, we observed a band at a higher molecular weight, which might be due to protein folding 
present in the VA-Mms6 peptide. As seen in lane 2, VA1 was not observed which is in 
consistent with the PAGE gel. A band was seen in lane 3 for VA2, confirming that the desired 
peptide was correctly expressed and purified. The His-ladder did not get resolved properly, 
because the ladder was not heated before loading into the wells. Changing the volume of ladder 
to be loaded and heating prior to loading might help in better resolution. Western Blot was done 
at Health Science Centre, WVU Morgantown WV with the help of Dr. Yogesh Kulkarni. 
 
3.4 Synthesis of Magnetite Nanoparticles 
 
To confirm that VA-Mms6, VA2 and VA3 can stimulate the formation of magnetite particles 
with defined structures, we have synthesized magnetite particles in the presence of VA-Mms6, 
VA2 and VA3. Figure 12(a) shows the SEM image and Figure 12(b) shows the Energy-









Figure 12: (a) SEM image of iron particles synthesized in the presence of VA-Mms6 (b) EDS of iron particles 
synthesized in the presence of VA-Mms6 
 
The particles synthesized in the presence of VA-Mms6 were confirmed to be iron particles by 
performing EDS. The iron and oxygen peak seen in the Figure 12(b) can be related to the 
presence of iron oxide particles. A large peak of copper is seen as it was used as a surface to dry 
the particles and hence it is the background. Carbon peak in the spectrum comes from the 
backbone of the peptide. However, the particles were heavily aggregated as seen in the SEM 
image. The reason for the aggregation is due to the presence of high charge surface on the 
peptide that nucleates the formation of iron particles. 
 
Figure 13(a) and Figure 13(b) show the SEM and EDS of particles synthesized in the presence of 
VA2. EDS analysis reveals the presence of iron particles. The peaks seen in Figure 13(b) can be 
attributed with the same reasoning as given for peaks in EDS in Figure 12(b) (above).  
 









(a)  (b) 
Figure 13: (a) SEM image of iron particles synthesized in the presence of VA2 (b) EDS of iron particles 
synthesized in the presence of VA3 
Similarly, SEM and EDS of synthesized particles in presence of VA3 is shown in Figures 14(a) 






Figure 14: (a) SEM image of iron particles synthesized in the presence of VA3 (b) EDS of iron particles 
synthesized in the presence of VA3 
Due to the presence of high-charge density on VA3 the synthesized particles were aggregating to 
a greater extent. EDS of the particles reveals that the synthesized particles in the presence of 
VA3 are iron particles. The same trend of iron, oxygen and copper peak was seen in Figure 14(b) 
as in Figure 12(b) and Figure 13(b). All the SEM measurements were performed by Adrienne 
McGraw (WVU). 













                        
Magnetite particles were also synthesized using polyethylene glycol (PEG). Figure 15 shows the 






Figure 15: SEM Image of magnetite particles synthesized in presence of (a) PEG-VA2 (b) PEG-VA3 
                                                                                           
There was greater tendency in the aggregation of particles when biocompatible polymer like 
PEG was attached to the peptides VA2 or VA3 to synthesize iron particle, Figure 15 depicts the 
same tendency. Characterization of iron particles synthesized with PEG-VA2 or PEG-VA3 can 
be carried out as future work for further qualitative and quantitative details of iron particles. 
 
3.5 Transmission Electron Microscopy (TEM) 
 
There was a huge difficulty in looking at the particles through SEM for particle size ranging 
from 50 to 100 nm, due to aggregation of particles. Due to the inherent limitation of SEM to 
provide only surface analysis, TEM was used to provide detailed sectional analysis in nano-
scale, which can be used to study synthesized iron particles for present work.  
 











Figure 16: TEM Images of magnetite particles synthesized in presence of (a) VA2 (b) VAMms6 (c) VA3 
 
The iron particles synthesized in the presence of VA2 (Figure 16a) were discrete, exhibiting a 
size range of 50 nm forming stable single magnetic domains. The iron particles exhibited a 
definite morphology. The iron particles synthesized in the presence of VA-Mms6 (Figure 16b) 
and VA3 (Figure 16c) were highly aggregated making it difficult to locate individual particles, 
due to this reason images of iron particles did not show a defined morphology in either of the 
case. VA2 has more number of carboxyl groups than VA-Mms6 and VA3. Discrete particles 
were seen when VA2 was used showing that the high charge of carboxyl groups was responsible 
in nucleating iron particles in size range of 50 nm. Particles synthesized with the aid of VA2 
were found to be similar in size and morphology with those produced by Arakaki et al. 
Visualization of particles synthesized with the aid of VA-Mms6 and VA3 was difficult. The 
sample preparation for TEM was done by Dr.Chaoying Ni. All the TEM measurements were 




3.6 X-Ray Photoelectron Spectroscopy 
 
XPS was run to determine the elemental composition and chemical state of the elements present 
in the sample. Figure 17 shows the XPS spectra of the synthesized iron particles in presence of 

























Fe 2p3/2 Fe 2p1/2
 
 
Figure 17: XPS spectra of magnetite particles synthesized in the presence of VA-Mms6, VA2, VA3 and XPS 
spectra of standard magnetite particles    
                                
XPS spectrum of individual samples is shown in Appendix B. A detail of the iron peaks (Fe 
2p1/2 and Fe 2p3/2) can be seen in Figure 17. The 2p3/2 peak shows a binding energy with a FeII 
component. In addition; in this case, the XPS analysis was very important in verifying the 
oxidation state of iron. The FeII/FeIII ratio, experimentally measured in different magnetite 
samples, ranged from 0.33 to 0.67. In the XPS spectrum, the binding energy signals appears at 
724.4 eV and 711.0 eV, which are the 2p electron orbit of iron atom in Fe3O4.43  In Figure 17 
XPS spectra of magnetite particles synthesized in presence of VA-Mms6 closely matches to the 
standard magnetite particle spectra. The XPS spectra of particles synthesized in the presence of 
VA2 and VA3 have a slight shift in the binding energy signals when seen in comparison to the 
standard. The shift in the peaks is due to the presence of Fe+2 and Fe+3 in non-stoichiometric 





(oxygen) to a normally empty valence level in Iron. The XPS analysis confirmed that the 
synthesized oxide was magnetite and was successfully synthesized in the presence of peptides 
VA-Mms6, VA2 and VA3. However particles synthesized in presence of VA2 and VA3 showed 
non-stoichiometric ratios of iron in magnetite. XPS was done by Srikanth Raghavan (WVU). 
3.7 Dynamic Light Scattering (DLS) 
 
In order to determine the size of synthesized magnetite particles in the presence of peptides, 





VAMms6 88 nm 
VA2 62 nm 
VA3 41 nm 
 
Figure 18: Size distribution of particles synthesized in the presence of (a) VA-Mms6 (b) VA2 and (c) VA3 
 
Particles synthesized in the presence of VA-Mms6 had a maximum distribution at a peak 
diameter of 88nm. Particles synthesized in the presence of VA2 and VA3 showed maximum size 






range 35-120nm form stable single magnetic domains and the magnetite particles synthesized in 
the presence of all the peptides fall in this size range. Particles synthesized using Mms6 by 
Arakaki and et al. was of size range 30 to 40nm. Magnetite particles synthesized in the presence 
of VA2 and VA3 closely matches with those produced by Mms6. The size range of VA2 was 
around 40nm when observed using a magnetic force microscopy against 60nm seen using 
dynamic light scattering. A possible reason is that the individual particles located in the scan 
region of magnetic force microscopy were of order 40nm. Dynamic light scattering was done 
with the help of Aaron Kessman. (WVU) 
 
3.8 Atomic Force Microscopy (AFM) 
 
Fe3O4 particles were dried on a silicon carbide wafer; this wafer was analyzed using AFM to 
observe the surface for magnetite particles. Particles were scanned in an area of 5µm×5µm. 
Figures 19(a), 19(b) and 19(c) show the AFM images of magnetite particles synthesized in 










Figure 19: AFM image of magnetite particles synthesized in the presence of (a) VA-Mms6 (b) VA2 (c) VA3 
 
The left half of each AFM image is the topography and the right half is the phase. The 
agglomeration of particles is seen in all the topography images. In case of magnetite particles 
synthesized in presence of VA-Mms6 they appeared more like a cloud whereas in presence of 
VA2 uniform size of particles is seen with defined morphology. In presence of VA3 magnetite 
particles are very difficult to locate individually. There was a difficulty in sample preparation as 








3.9 Magnetic Force Microscopy (MFM) 
 
Magnetic force microscopy was done on particles synthesized in presence of VAMms6, VA2 
and VA3 in order to find magnetic domains. Figure 20 shows the MFM image of magnetite 
particles synthesized in the presence of VA2.   
 
 
Figure 20: MFM image of magnetite particles synthesized in presence of VA2 
 
The first part of the MFM analysis consisted in locating a region where individual particles can 
be seen in domains. In this region, lift mode MFM revealed that all the domains stay in different 
directions with defined parallel strips due to the anisotropy. Well-defined walls and domains 
shifts were interpreted as negative (repulsion) in bright regions, while positive (attraction) in 
dark regions. Domains formed in the magnetic field were measured in a range of 30–40nm by 
the profile following transversal direction across the domains.  
 




Magnetic domains were seen only in the case of particles synthesized in presence of VA2 
(Figure 20). This confirmed the magnetic nature of particles formed. The size range of particles 
(40nm) observed falls in the region of particles with single magnetic domains. This is a slight 
decrease in the size of particles when seen against dynamic light scattering results for particles 
synthesized using VA2. In case of particles synthesized with the aid of VAMms6 and VA3, 
individual particles could not be located because of aggregation. Another possibility is that the 
polymer is covering the particles making it even more difficult for the magnetic interactions to 
be seen as an image. Care should be taken that the interleave height is small enough for the 
magnetic interactions between the tip and surface to be seen. Very small heights might crash the 
tip. So, an optimum interleave height of 100nm should be maintained. MFM image of VA2 
confirms the presence of magnetite nanoparticles with single magnetic domains of the size 40nm. 



























Conclusions and Future Directions 
 
The proposed mechanism in this study states that the Mms6 is a magnetosome membrane-
associated protein and the hydrophilic C-terminal domain, which contains acidic acids, forms a 
negatively charged surface. The carboxyl groups together with hydroxyl groups may serve as the 
template for iron binding and the formation of magnetite particles with defined size and 
morphology. 
 
The investigation of sizes and morphologies of magnetite nanoparticles synthesized in the 
presence of VAMms6, VA2 and VA3 suggested that carboxyl groups and hydroxyl groups 
control the size and morphology. Discrete particles were seen using VA2, attributing to the high 
charge of carboxyl groups. The charge density of VA2 is much higher than VA-Mms6 or VA3. 
Formation of magnetite nanoparticles was supported by XPS results and the MFM image of 
nanoparticles formed in the presence of VA2, further supports the magnetic behavior of the 
synthesized particles. MFM images of nanoparticles synthesized in the presence of VA2 shows 
that nanoparticles are of size range 40nm. Dynamic light scattering results of particles 
synthesized in the presence of VA-Mms6, VA2 and VA3 showed a maximum size distribution at 
peak diameters of 88nm, 62nm and 41nm respectively. Owing to the size of nanoparticles from 
MFM and DLS, a conclusion can be drawn that they form stable single magnetic domains. The 
attempt to make magnetite particles by changing the functional groups in Mms6 into carboxyl 
(VA2) was successful. Discrete particles were not visualized using VA-Mms6 and VA3. 
 
Finally, based on the above observations and the experimental results, it is proposed that 
carboxyl group‟s peptides have a better control over the size and morphology of magnetite 
nanoparticles. The negatively charged surface of VA2 serves as a template for the formation of 





There are several questions that need to be addressed in the near future. First, all the data 
regarding the sizes and morphologies of nanoparticles were just qualitative, further quantitative 
magnetic property measurements of the synthesized magnetite nanoparticles are required. 
Second, the synthesized magnetic particles always tend to aggregate and this behavior can be 
understood by studying the structure of Mms6, VA2 and VA3. The structural study will give a 
better idea of the structure relationship of Mms6, VA2, and VA3 to the formation of magnetite 
nanoparticles. And finally, the measurements of iron binding activities of VA2 should be carried 
out as it would help in producing quantitative data regarding the binding constant of iron to VA2. 
 
An attempt was made in this study in synthesizing magnetite particles in presence of peptides 
coupled with biocompatible polymer PEG. Further studies should be carried out in characterizing 
the particles that are synthesized using PEG. The potential challenge in future would be film 
coating synthesized magnetite nanoparticles with a biocompatible and non-toxic polymer like 
PEG, dextran or chitosan. Magnetite particles are used as a contrast agent in MRI for better 
resolution of human internal structures. Usage of magnetite particles reduces noise signals of 
absorbing tissues. Hence the functionalized magnetite particles can be effectively used in 
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Expected # of 
Residues 
cm-cys 0.065 0.30  0.30%  
Asx 3.952 18.41 20.59 -2.18% 14 
Thr 0.244 1.14  1.14%  
Ser 0.897 4.18 4.41 -0.23% 3 
Glx 3.620 16.87 17.65 -0.78% 12 
Pro      
Gly 2.577 12.01 11.76 0.24% 8 
Ala 2.020 9.41 8.82 0.59% 6 
Cys      
Val 1.480 6.90 5.88 1.01% 4 
Met 0.178 0.83 2.94 -2.11% 2 
Ile 0.670 3.12 2.94 0.18% 2 
Leu 0.949 4.42 2.94 1.48% 2 
Tyr 0.153 0.71  0.71%  
Phe 0.193 0.90  0.90%  
His 2.449 11.41 13.24 -1.82% 9 
Lys 0.812 3.78 2.94 0.84% 2 
TRP      
Arg 1.204 5.61 5.88 -0.27% 4 




21.46   68 
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Total 
Nmol/Inj.: 21.46   68 

















































































































 XPS spectra of magnetite particles synthesized in the presence of (a) VA-Mms6, (b) VA2, (c)VA3 and (d) 
standard magnetite particles    
 
